Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2

To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...

Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2

To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...

A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma

Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Nine out of 10 patients who have received CP outsid...

Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing

SARS-CoV-2 nucleic acid testing (NAT) has been routinely used for diagnosis during this pandemic. There have been concerns about its high false-negati...

Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2

SARS-CoV-2 has caused a worldwide pandemic of coronavirus disease 2019 or COVID-19. Coronaviruses generate subgenomic RNAs through a process involving...

Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review

Numerous cases of the coronavirus disease 2019 (COVID-19) with autoimmune and rheumatic manifestations have been reported. Most of the existing eviden...

Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2

To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...